来自Chenopodium serotinum L.,一种永恒的野生蔬菜,具有α-葡萄糖酶抑制活性的奥莱类型葡萄糖化物
Chien-Yi Chen1, Sheau-Ling Ho2, Sheng-Fa Tsai1
1School of Pharmacy, College of Medicine, National Taiwan University, Taipei 10050, Taiwan, Republic of China.
Journal of agricultural and food chemistry
|November 17, 2025
概括
从Chenopodium serotinum中分离出了七种新的oleanane类型的三甲基糖化物,也就是A-G类的诺. 陈诺因A对α-葡萄糖酶表现出适度的活性,这表明了潜在的治疗应用.
科学领域:
- 自然产品化学 自然产品化学
- 药理学是指药理学,即药理学是指药理学.
- 药用化学 医学化学
背景情况:
- Chenopodium serotinum L. (Chenopodiaceae) 是一种传统的民间药物,具有记录的抗炎和排毒特性.
- 对其化学成分的探索可以揭示新的生物活性化合物.
研究的目的:
- 从Chenopodium serotinum中分离和表征新的奥莱安类型的三基酸糖化物.
- 为了评估这些化合物对α-葡萄糖酶的抑制活性.
主要方法:
- 使用各种色谱技术 (Sephadex LH-20,HPLC) 来分离化合物.
- 通过广泛的光谱分析 (1D/2D NMR,MS) 阐明结构.
- 在体外的α-葡萄糖酶抑制测定和分子对接用于虚拟选.
主要成果:
- 成功分离了七种新型的烯类三基化物,称为陈诺素AG.
- 其中六种化合物是罕见的3-O-triosides,突出显示了该属内的结构新性.
- 陈诺尼A表现出中度的α-葡萄糖酶抑制活性,其IC50值为23.25±1.00μM.
结论:
- 这项研究确定了来自Chenopodium serotinum的新型三基酸糖化物.
- 陈诺 A 显示出作为α-葡萄糖酶抑制剂的潜力,需要进一步研究其治疗益处.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
509
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
509
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
890
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
890
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.0K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.0K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
1.4K
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
1.4K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K


